EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds

Inclusion Criteria: * Is the patient at least 18 years of age * Is the patient male, or is not pregnant or lactating and is using contraception * Has the patient been diagnosed with a non-melanoma skin cancer (basal cell carcinoma BCC or squamous cell carcinoma SCC) for which the chosen therapeutic option is surgical excision followed by secondary intention healing * Is the excisional wound greater than 10mm x 10mm in size and less than or equal to 35mm x 35mm after any attempt at primary closure * Does the patient have limited skin laxity which would make primary closure of the surgical excision difficult * Is the patient able to understand the aims and objectives of the trial and are they willing to consent Exclusion Criteria: * Has the patient been diagnosed with any transmittable viral diseases (HIV, Hepatitis B or C) * Has the patient been diagnosed with, or is it suspected that they have metastatic disease * Does the patient have a history of malignant melanoma or any concomitant disease likely to impede wound healing * Has the patient been diagnosed with pre-existing wound infection * Is the patient taking any medication known to interfere with skin grafts (i.e. warfarin and other anticoagulants, steroids, NSAIDs and immunosuppressants) * Has the excised wound been entirely treated by primary closure * Does the patient have a history of any significant cardiac, pulmonary, renal, hepatic, neurological and/ or immune dysfunction that may affect wound healing * Does the patient know of any allergy to any of the device materials to be used in the trial * Does the patient have a known history of poor compliance with medical treatment * Has the patient participated in this trial previously and healed or been withdrawn * Is the patient currently participating in any other clinical trial